Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
14
02
2020
accepted:
05
10
2020
pubmed:
31
10
2020
medline:
3
7
2021
entrez:
30
10
2020
Statut:
epublish
Résumé
Transplantation of lungs from donation after circulatory death (DCD) in addition to donation after brain death (DBD) became routine worldwide to address the global organ shortage. The development of Tissue biopsies from human DBD (n=177) and DCD (n=65) donor lungs, assessed with or without EVLP, were collected at the end of cold ischaemic time. All samples were processed with microarray assays. Gene expression, network and pathway analyses were performed using R, Ingenuity Pathway Analysis and STRING. Results were validated with protein assays, multiple logistic regression and 10-fold cross-validation. Our analyses showed that lungs from DBD donors have upregulation of inflammatory cytokines and pathways. In contrast, DCD lungs display a transcriptome signature of pathways associated with cell death, apoptosis and necrosis. Network centrality revealed specific drug targets to rehabilitate DBD lungs. Moreover, in DBD lungs, tumour necrosis factor receptor-1/2 signalling pathways and macrophage migration inhibitory factor-associated pathways were activated in the EVLP group The examination of gene expression profiling indicates that DBD and DCD lungs have distinguishable biological transcriptome signatures.
Identifiants
pubmed: 33122335
pii: 13993003.00327-2020
doi: 10.1183/13993003.00327-2020
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : MOP-31227
Pays : Canada
Organisme : CIHR
ID : MOP-119514
Pays : Canada
Organisme : CIHR
ID : PJT-148847
Pays : Canada
Informations de copyright
Copyright ©ERS 2021.
Déclaration de conflit d'intérêts
Conflict of interest: C. Baciu has nothing to disclose. Conflict of interest: A. Sage has nothing to disclose. Conflict of interest: R. Zamel has nothing to disclose. Conflict of interest: J. Shin has nothing to disclose. Conflict of interest: X-H. Bai has nothing to disclose. Conflict of interest: O. Hough has nothing to disclose. Conflict of interest: M. Bhat has nothing to disclose. Conflict of interest: J.C. Yeung has nothing to disclose. Conflict of interest: M. Cypel has nothing to disclose. Conflict of interest: S. Keshavjee reports grants from Canadian Institutes of Health Research (operating grants MOP-31227, MOP-119514 and PJT-148847) and Genome Canada (Genomic Application Partnership Program grant 6427), during the conduct of the study. Conflict of interest: M. Liu reports grants from Canadian Institutes of Health Research (operating grants MOP-31227, MOP-119514 and PJT-148847) and Genome Canada (Genomic Application Partnership Program grant 6427), during the conduct of the study.